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Summary
To evaluate the utility of cardiovascular magnetic reso-
nance (CMR) in detection of individuals with patho-
genic/ presumed pathogenic (PA/ PP) sarcomeric
mutations and gene negative patients with high clinical
probability of HCM but with a negative phenotype by
standard diagnostic criteria.
Background
Mutation carriers without hypertrophy - gene positive,
phenotype negative (G+P-) - are not uncommon in clin-
ical practice. There is debate about the presence of
subtle abnormalities or variants of the left ventricle in G
+P- individuals. Previous research into this area only
evaluated limited mutations in the myosin binding pro-
tein C and a-tropomyosin genes. We hypothesized: 1)
that G+P- patients with pathogenic or presumed patho-
g e n i c( P A / P Pm u t a t i o n s )h a v es u b t l ea b n o r m a l i t i e so f
LV morphology recognisable by CMR in pre-clinical
HCM but absent in a control population; and 2) that
these signs are also present in gene negative patients
with a normal wall thickness (G-P-) but high clinical
probability of HCM (based on assessment of clinical or
family history, electrocardiographic or echocardiographic
criteria).
Methods
The study population had 3 groups - Group 1 (G+P-,
tested positive for PA/ PP mutations, n=18); Group 2
(G-P-, Under evaluation for HCM, tested negative for
[PA/ PP] mutations, n=20); and Group 3 (controls,
n=36). Two experienced CMR readers (blinded to
results of genetic testing and clinical context) scored
each case for probability of the case representing HCM
based on pre-defined signs at CMR including the pre-
sence/absence of: a) deep basal inferoseptal crypts
(DBISC); b) sudden wall thickness change by >50% in
adjacent segments (SWTC); c) inappropriate wall thin-
ning (IWT); d) apical-basal false tendon (ABFT); e) lack
of apical tapering (LAT); f) snub nose apical contour
(SNAC) . Cases were reviewed individually and in con-
sensus. An experienced HCM cardiologist (blinded to
CMR findings) reviewed clinical data, electrocardio-
grams and echocardiograms and scored each case for
likelihood of HCM.
Results
O ft h e1 8G + P -p a t i e n t s ,7 8 %h a dD B I S C ,6 7 %h a da n
ABFT, 50% had IWT and 39% had SWTC. DBISC were
seen in cases with PA/PP MYBPC3, TPM1, TNNT2 and
MYH7 mutations. All G+P- cases had at least one subtle
sign. All G-P- cases classified clinically as high probabil-
ity of HCM, were classified as high probability of HCM
on imaging grounds and had 2 or more subtle signs of
H C M :D B I S C ,S W T C ,I W T ,A B F T ,S N A Ca n dL A T .
Controls had no DBISC, SWTC, IWT or LAT.
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Subtle structural abnormalities visible on CMR help
identify PA/PP sarcomeric mutation carriers, as well as
G- P- with high clinical probability of HCM, in a geneti-
cally heterogenous population.
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Table 1 Incidence of Subtle Signs in G+P- Group and
Controls
Sign G+P- Group (n=18) Controls (n=36)
DBISC 14 (77.8%) 0 (0%)
SWTC 7 (38.9%) 0 (0%)
IWT 9 (50%) 0 (0%)
ABFT 12 (66.7%) 2 (5.6%)
LAT 1 (5.6%) 0 (0%)
SNAC 1 (5.6%) 1 (2.8%)
(DBISC - Deep Basal Inferoseptal Crypts, SWTC - Sudden Wall Thickness
Change, IWT - Inappropriate Wall Thinning, ABFT - Apical to Basal False
Tendon, LAT - Lack of Apical Tapering, SNAC - Snub Nose Apical Contour).
DBISC are defined as focal defects in the basal inferoseptum with a depth of
greater than 50% relative to immediate surrounding myocardium. SWTC is
defined as sudden transition in wall thickness between adjacent myocardial
segments with a ratio of thicker to thinner myocardium of 2:1 or greater
(excluding the thin myocardium of the true apex) IWT is defined as wall
thinning out of keeping with the thickness of adjacent myocardial segments
or segments within the ring of myocardium that segment is located in. ABFT
is defined a false tendon extending from the basal ventricle to apical
compacted myocardium. LAT is defined as apical myocardial tapering not
conforming to normality (typically the myocardium tapers smoothly towards
the apex becoming progressively thinner till it reaches the thin myocardium
of the tip of the true apex. SNAC is defined as a flattened or blunted
epicardial contour in systole akin to the shape of the tip of a ballet dancer’s
shoe.
Figure 1 Basal 4 chamber orientation image from an SSFP cine
stack demonstrating multiple deep basal inferoseptal crypts (DBISC)
in a 20 year old female with a pathogenic p.Glu163del TNNT2
mutation.
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